The Navigation Guide Systematic Review Methodology: A Rigorous and Transparent Method for Translating Environmental Health Science into Better Health Outcomes
暂无分享,去创建一个
[1] R. Courtney,et al. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for: Critique , 2015 .
[2] Oar Us Epa,et al. Benefits and Costs of the Clean Air Act , 2015 .
[3] L. Giudice,et al. State of the Science of Endocrine Disrupting Chemicals - 2012 , 2012 .
[4] A. B. Hill,et al. "The Environment and Disease: Association or Causation?" (1965), by Austin Bradford Hill , 2017 .
[5] Ord,et al. Guidelines for Reproductive Toxicity Risk Assessment , 2014 .
[6] Ord,et al. Guidelines for Developmental Toxicity Risk Assessment , 2014 .
[7] Tracey J. Woodruff,et al. The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.
[8] Division on Earth. Review of Epa's Integrated Risk Information System (Iris) Process , 2014 .
[9] Paula I. Johnson,et al. The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.
[10] Paula I. Johnson,et al. The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.
[11] John R. Bucher,et al. Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.
[12] Oladele A Ogunseitan,et al. Dempster‐Shafer theory applied to regulatory decision process for selecting safer alternatives to toxic chemicals in consumer products , 2014, Integrated environmental assessment and management.
[13] Lisa A Bero,et al. Why the Cochrane risk of bias tool should include funding source as a standard item. , 2013, The Cochrane database of systematic reviews.
[14] Igor Linkov,et al. Use of multi‐criteria decision analysis in regulatory alternatives analysis: A case study of lead free solder , 2013, Integrated environmental assessment and management.
[15] T. Woodruff,et al. Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental health perspectives.
[16] Linda S. Birnbaum,et al. Implementing Systematic Review at the National Toxicology Program: Status and Next Steps , 2013, Environmental health perspectives.
[17] P. Grandjean,et al. Late lessons from early warnings: science, precaution, innovation , 2013 .
[18] Assuring Access to Data for Chemical Evaluations , 2012, Environmental health perspectives.
[19] S. Lazic,et al. A call for transparent reporting to optimize the predictive value of preclinical research , 2012, Nature.
[20] Paul T Anastas,et al. Barriers to the implementation of green chemistry in the United States. , 2012, Environmental science & technology.
[21] E. Ha,et al. Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes , 2012, PloS one.
[22] D. Bellinger. Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factors. , 2012, Neurotoxicology.
[23] D. Howells,et al. Improving the Efficiency of the Development of Drugs for Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.
[24] Gloria B Post,et al. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. , 2012, Environmental research.
[25] P. Santaguida,et al. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions , 2012 .
[26] Sergio Sismondo,et al. Industry sponsorship and research outcome. , 2012, The Cochrane database of systematic reviews.
[27] T. Stahl,et al. Toxicology of perfluorinated compounds , 2011 .
[28] Peter L. Tsai,et al. Global Benefits from the Phaseout of Leaded Fuel , 2011 .
[29] M. Macleod,et al. Preclinical studies of human disease: time to take methodological quality seriously. , 2011, Journal of molecular and cellular cardiology.
[30] S. Fenton,et al. Endocrine disrupting properties of perfluorooctanoic acid , 2011, The Journal of Steroid Biochemistry and Molecular Biology.
[31] Mark J. Strynar,et al. Polyfluorinated compounds: past, present, and future. , 2011, Environmental science & technology.
[32] J. Giesy,et al. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. , 2011, Environmental science & technology.
[33] T. Fletcher,et al. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.
[34] Jody A. Roberts,et al. Why the toxic substances control act needs an overhaul, and how to strengthen oversight of chemicals in the interim. , 2011, Health affairs.
[35] J. Dowd,et al. Discovering how environmental exposures alter genes could lead to new treatments for chronic illnesses. , 2011, Health affairs.
[36] L. Trasande,et al. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. , 2011, Health affairs.
[37] Patrice Sutton,et al. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.
[38] Howard Balshem,et al. GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.
[39] G. Guyatt,et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.
[40] Joel Lexchin,et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. , 2011, JAMA.
[41] M. Macleod,et al. Treatment of intracerebral hemorrhage in animal models: Meta‐analysis , 2011, Annals of neurology.
[42] P. Schlattmann,et al. Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[44] K. Kannan,et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. , 2011, Environmental pollution.
[45] B. Koletzko,et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). , 2010, Environmental science & technology.
[46] M. Macleod,et al. Improving the translational hit of experimental treatments in multiple sclerosis , 2010, Multiple sclerosis.
[47] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[48] David W Howells,et al. Factors Affecting the Apparent Efficacy and Safety of Tissue Plasminogen Activator in Thrombotic Occlusion Models of Stroke: Systematic Review and Meta-Analysis , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] Carlijn R Hooijmans,et al. Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed , 2010, Laboratory animals.
[50] Jonathan I Levy,et al. Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.
[51] Samuel Y. Sessions. The Convergence of Science and Governance: Research, Health Policy, and American States , 2010 .
[52] Drummond Rennie,et al. Integrity in scientific publishing. , 2010, Health services research.
[53] D. Savitz,et al. Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.
[54] F. Valet,et al. Relationship between Sponsorship and Failure Rate of Dental Implants: A Systematic Approach , 2010, PloS one.
[55] Anna Beronius,et al. Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A. , 2010, Reproductive toxicology.
[56] T. Woodruff,et al. Environmental impacts on reproductive health and fertility , 2010 .
[57] D. Fox. The Convergence of Science and Governance: Research, Health Policy, and American States , 2010 .
[58] D. Fox,et al. The Convergence of Science and Governance , 2010 .
[59] L. Giudice,et al. Comprar Environmental Impacts on Reproductive Health and Fertility | Tracey J. Woodruff | 9780521519526 | Cambridge University Press , 2010 .
[60] J. Heindel,et al. Environmental Impacts on Reproductive Health and Fertility: Developmental exposures and implications for early and latent disease , 2010 .
[61] Christopher J. Portier,et al. IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS PReAMBLe , 2011 .
[62] P. Glasziou,et al. Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.
[63] G. Olsen,et al. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. , 2009, Reproductive toxicology.
[64] Steven G. Gilbert,et al. Doubt Is Their Product: How Industry’s Assault on Science Threatens Your Health , 2009, Environmental Health Perspectives.
[65] R. Luebke,et al. Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha , 2009, Critical reviews in toxicology.
[66] R. Luebke,et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. , 2009, Critical reviews in toxicology.
[67] D. Rennie,et al. Assessing authority. , 2009, JAMA.
[68] U. Dirnagl,et al. Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality , 2008, Stroke.
[69] D. Altman,et al. Chapter 8: Assessing risk of bias in included studies , 2008 .
[70] G. Guyatt,et al. Going from evidence to recommendations , 2008, BMJ : British Medical Journal.
[71] B. McNeil,et al. Knowing What Works in Health Care: A Roadmap for the Nation , 2008 .
[72] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[73] A. A. Jensen,et al. Emerging endocrine disrupters: perfluoroalkylated substances. , 2008, International journal of andrology.
[74] D. Gee. Establishing evidence for early action: the prevention of reproductive and developmental harm. , 2008, Basic & clinical pharmacology & toxicology.
[75] G. Donnan,et al. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. , 2007, Brain : a journal of neurology.
[76] M. Glass,et al. Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences , 2007, British journal of pharmacology.
[77] C. Lau,et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[78] Lisa Bero,et al. Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others , 2007, PLoS medicine.
[79] Andrew Nugent,et al. Emergency medicine. , 2007, Clinical privilege white paper.
[80] Andrea Pfahles-Hutchens,et al. The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health Continuum , 2006, Environmental health perspectives.
[81] J. Grauer,et al. Industry Support and Correlation to Study Outcome for Papers Published in Spine , 2005, Spine.
[82] C. Lau,et al. The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.
[83] Jeffrey H Mandel,et al. Characterization of risk for general population exposure to perfluorooctanoate. , 2004, Regulatory toxicology and pharmacology : RTP.
[84] David W Howells,et al. Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias , 2004, Stroke.
[85] Roger G Perkins,et al. The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.
[86] Kennon Heard,et al. Emergency medicine animal research: does use of randomization and blinding affect the results? , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[87] B. Djulbegovic,et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.
[88] Yoichi Kawashima,et al. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.
[89] Pim de Voogt,et al. Environmental and toxicity effects of perfluoroalkylated substances. , 2003, Reviews of environmental contamination and toxicology.
[90] L. Bero,et al. Why review articles on the health effects of passive smoking reach different conclusions. , 1998, JAMA.
[91] L. Bero,et al. Scientific quality of original research articles on environmental tobacco smoke , 1997, Tobacco Control.
[92] D. Sliney. Ultraviolet radiation exposure dosimetry of the eye : a report to the World Health Organization and United Nations Environment Programme , 1995 .
[93] F. Mosteller,et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.
[94] Batavia Mk,et al. Clean Air Act Amendments of 1990. , 1991 .
[95] 金錫俊. 1990 , 1990, Literatur in der SBZ/DDR.
[96] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.